Utreloxastat 是一种用于研究包括 α-突触核蛋白病、tau 蛋白病、ALS、创伤性脑损伤和缺血再灌注相关损伤在内的疾病的化合物。
| Cas No. | 1213269-96-5 |
| 分子式 | C18H28O2 |
| 分子量 | 276.41 |
| 溶解度 | DMSO : 12.5 mg/mL (45.22 mM; ultrasonic and warming and heat to 60°C) |
| 储存条件 | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request |
| 产品描述 | Utreloxastat is a compound used for the research of the disorders including α-synucleinopathies, tauopathies, Amyotrophic lateral sclerosis (ALS), traumatic brain injury, and ischemic-reperfusion related injuries (patent WO2020081879A2, example A1)[1]. [1]. Andrew W. Hinman, et al. 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING α-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS. WO2020081879A2. |
